Compare PIPR & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PIPR | GRFS |
|---|---|---|
| Founded | 1895 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.9B |
| IPO Year | 2003 | 2008 |
| Metric | PIPR | GRFS |
|---|---|---|
| Price | $65.50 | $7.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $80.88 | $10.87 |
| AVG Volume (30 Days) | ★ 700.5K | 429.1K |
| Earning Date | 10-30-2026 | 07-28-2022 |
| Dividend Yield | ★ 3.18% | 1.16% |
| EPS Growth | ★ 54.49 | N/A |
| EPS | ★ 1.87 | N/A |
| Revenue | ★ $1,904,217,000.00 | N/A |
| Revenue This Year | $9.70 | $1.73 |
| Revenue Next Year | $12.44 | $6.26 |
| P/E Ratio | $34.43 | ★ $18.67 |
| Revenue Growth | ★ 24.33 | N/A |
| 52 Week Low | $62.69 | $6.96 |
| 52 Week High | $380.26 | $9.90 |
| Indicator | PIPR | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 34.67 | 50.11 |
| Support Level | N/A | $7.44 |
| Resistance Level | $77.95 | $8.36 |
| Average True Range (ATR) | 2.37 | 0.13 |
| MACD | -0.41 | 0.03 |
| Stochastic Oscillator | 21.68 | 79.52 |
Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.